Multi-pharmaceutical companies said: innovative drugs began to contribute to performance and realize value realization
Time of Update: 2022-09-06
Innovative drugs have begun to contribute to performance (Source: Pharmaceutical Network) For example, Kelun Pharmaceutical stated in its mid-year report that in addition to the large volume of generic drugs, the company has also ushered in a new growth point, that is, innovative drug research and development has begun to contribute revenue .
Shenhua Coal-to-Olefin Project Contributed Performance and Profitable Prospects
Time of Update: 2022-02-28
. During the 13th Five-Year Plan period, the coal chemical industry will maintain the current scale of production and construction, and will not continue to expand for the time being .
National Health And Wellness Commission: No contribution can not be named papers! Not tied to performance or bonuses
Time of Update: 2021-03-24
Within 1 month after the publication of relevant papers and other scientific research results , To submit the original information to the institution After the completion of the research, medical scientific research personnel shall follow the corresponding biosafety and scientific research management regulations for the storage, sharing and destruction of human or animal samples, toxic substances, data or materials.
Xinda biology's mid-term performance in 2019: total revenue of 350 million yuan, and dabushu's contribution of 330 million yuan
Time of Update: 2019-08-29
Xinda biopharmaceutical Co., Ltd is a biopharmaceutical company dedicated to the research, development, production and sales of innovative drugs for the treatment of major diseases such as cancer and